Bian W, Gonzalez O, De Lecea L
Sleep. 2023; 46(7).
PMID: 37144901
PMC: 10334736.
DOI: 10.1093/sleep/zsad131.
de Bartolomeis A, Vellucci L, De Simone G, Mazza B, Barone A, Ciccarelli M
Cells. 2023; 12(4).
PMID: 36831241
PMC: 9954794.
DOI: 10.3390/cells12040574.
Gao L, Zhao J, Ardiel E, Hall Q, Nurrish S, Kaplan J
Elife. 2022; 11.
PMID: 35266450
PMC: 8937234.
DOI: 10.7554/eLife.75140.
Wan L, Ai J, Yang C, Jiang J, Zhang Q, Luo Z
Front Aging Neurosci. 2021; 13:717263.
PMID: 34504419
PMC: 8421777.
DOI: 10.3389/fnagi.2021.717263.
Neklyudova A, Portnova G, Rebreikina A, Voinova V, Vorsanova S, Iourov I
Int J Mol Sci. 2021; 22(4).
PMID: 33673024
PMC: 7917917.
DOI: 10.3390/ijms22041898.
Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries.
Wan L, Liu D, Xiao W, Zhang B, Yan X, Luo Z
Cell Mol Neurobiol. 2021; 42(6):1623-1643.
PMID: 33595806
PMC: 11421742.
DOI: 10.1007/s10571-021-01054-x.
22q13 Microduplication Syndrome in Siblings with Mild Clinical Phenotype: Broadening the Clinical and Behavioral Spectrum.
Ujfalusi A, Nagy O, Bessenyei B, Lente G, Kantor I, Borbely A
Mol Syndromol. 2020; 11(3):146-152.
PMID: 32903739
PMC: 7445545.
DOI: 10.1159/000507103.
A 22q13.33 duplication harbouring the SHANK3 gene: does it cause neuropsychiatric disorders?.
Johannessen M, Haugen I, Bakken T, Braaten O
BMJ Case Rep. 2019; 12(11).
PMID: 31678916
PMC: 6827803.
DOI: 10.1136/bcr-2018-228258.
Combined cellomics and proteomics analysis reveals shared neuronal morphology and molecular pathway phenotypes for multiple schizophrenia risk genes.
Rosato M, Stringer S, Gebuis T, Paliukhovich I, Li K, Posthuma D
Mol Psychiatry. 2019; 26(3):784-799.
PMID: 31142819
PMC: 7910218.
DOI: 10.1038/s41380-019-0436-y.
Integrative Brain Transcriptome Analysis Reveals Region-Specific and Broad Molecular Changes in -Overexpressing Mice.
Jin C, Kang H, Ryu J, Kim S, Zhang Y, Lee Y
Front Mol Neurosci. 2018; 11:250.
PMID: 30233305
PMC: 6127286.
DOI: 10.3389/fnmol.2018.00250.
Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.
Soler J, Fananas L, Parellada M, Krebs M, Rouleau G, Fatjo-Vilas M
J Psychiatry Neurosci. 2018; 43(4):223-244.
PMID: 29947605
PMC: 6019351.
DOI: 10.1503/jpn.170066.
USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.
Kerrisk Campbell M, Sheng M
J Neurosci. 2018; 38(23):5289-5301.
PMID: 29735556
PMC: 6596000.
DOI: 10.1523/JNEUROSCI.3305-17.2018.
Neurodevelopmental disease mechanisms, primary cilia, and endosomes converge on the BLOC-1 and BORC complexes.
Hartwig C, Monis W, Chen X, Dickman D, Pazour G, Faundez V
Dev Neurobiol. 2017; 78(3):311-330.
PMID: 28986965
PMC: 5816705.
DOI: 10.1002/dneu.22542.
Striatal Transcriptome and Interactome Analysis of -overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling.
Lee Y, Kim S, Lee B, Zhang Y, Kim Y, Kim S
Front Mol Neurosci. 2017; 10:201.
PMID: 28701918
PMC: 5487420.
DOI: 10.3389/fnmol.2017.00201.
Shank is a dose-dependent regulator of Ca1 calcium current and CREB target expression.
Pym E, Sasidharan N, Thompson-Peer K, Simon D, Anselmo A, Sadreyev R
Elife. 2017; 6.
PMID: 28477407
PMC: 5432211.
DOI: 10.7554/eLife.18931.
Integrative Analysis of Brain Region-specific Shank3 Interactomes for Understanding the Heterogeneity of Neuronal Pathophysiology Related to Mutations.
Lee Y, Kang H, Lee B, Zhang Y, Kim Y, Kim S
Front Mol Neurosci. 2017; 10:110.
PMID: 28469556
PMC: 5395616.
DOI: 10.3389/fnmol.2017.00110.
Shank Modulates Postsynaptic Wnt Signaling to Regulate Synaptic Development.
Harris K, Akbergenova Y, Cho R, Baas-Thomas M, Littleton J
J Neurosci. 2016; 36(21):5820-32.
PMID: 27225771
PMC: 4879199.
DOI: 10.1523/JNEUROSCI.4279-15.2016.
Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders.
Choi S, Pang K, Kim J, Ryu J, Kang H, Liu Z
Mol Brain. 2015; 8(1):74.
PMID: 26572867
PMC: 4647645.
DOI: 10.1186/s13041-015-0165-3.
Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3.
Uchino S, Waga C
Curr Neuropharmacol. 2015; 13(6):786-92.
PMID: 26511836
PMC: 4759317.
DOI: 10.2174/1570159x13666151029105547.
Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H, De Rubeis S, Kolevzon A, Buxbaum J
J Child Neurol. 2015; 30(14):1861-70.
PMID: 26350728
PMC: 5321557.
DOI: 10.1177/0883073815600872.
